FDA Investigator Santos E Camara

Santos E Camara has inspections in 22 countries as of 26 Aug 2023. Santos E Camara has collaborated with a combinined 7024 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
77
Last Inspection Date:
26 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
India, Malaysia, Japan, China, France, United Kingdom of Great Britain and Northern Ireland, Singapore, Germany, United States of America, Belgium, Austria, Switzerland, Argentina, Taiwan, Spain, Korea (Republic of), Ireland, Malta, Netherlands, Hungary, Mexico
Co-Investigator(s):
Aaron P Wozniak, Abby M Miller, Adam R Cooke, Ademola O Daramola, Agnes M Santori, Alan P Kurtzberg, Alice S Tsao, Alicia K Mckinsey, Ana P Pineda Zavaleta, Anastasia G Lolas, Angela E Glenn, Anita Narula, PhD, Anjali Shukla, PhD, Ann L Demarco, Anna Lazar, Anthony F Lorenzo, April L Young, Ariel Cruz Figueroa, Arsen Karapetyan, Ashley N Queen, PhD, Ashutosh Rao, PhD, Azza Talaat, Barbara Janine Breithaupt, Bichsa T Tran, Bijoy Panicker, Bingchen Du, Binh T Nguyen, Blondell W Johnson, Bo Chi, PhD, Bonita S Chester, Brandon C Heitmeier, Brenda Rivera, Brittny C Cargo, Brooke K Higgins, Bruce H Mccullough, Bryan L Mcguckin, Burnell M Henry, Camerson E Moore, Carl A Huffman, III, Carla A Norris, Carla J Lundi, Carlos A Medina, Caroline Strasinger, Carolyn A Renshaw, Carrie A Hughes, Cary Greene, Caryn M Mcnab, Cassandra L Winters, CDR Ileana Barreto Pettit, CDR Thomas R Berry, PPh, Cecilia H Kieu, Charanjeet Jassal, Christian D Lynch (CDL), Christopher D Leach, Christopher R Czajka, Christopher T Middendorf, Claire M Minden, Cody D Rickman, Concepcion Cruz, Jr, Constantin Y Philopoulos, Cynthia Jim, CSO, Cynthia M Goudeau, Daniel J Lahar, Daniel J Roberts, Daniel Lahar, Darren S Brown, David Doteski, David G Eng, David Perkins, Dawn E Barkans, Dayna I Martinez, Deborah A Greco, Dennis Cantellops Paite, Devaugh Edwards, Devaughn Edwards, Diane L Raccasi, Dipesh K Shah, Doan T Nguyen, PharmD, Don H Bark, PhD, Donald C Obenhuber, PhD, Dongping Dai, PhD, Douglas A Campbell, Douglas C Kovacs, Dr. Jason R Caballero, Dr. Ralph M Bernstein, PhD, Edmund F Mrak, Jr, Edward D Edmiston, Edwin Martinez, Eileen A Liu, Emest F Bizjak, Emilio O Escobar, Erika E Englund, PhD, Erika V Butler, Farhana Khan, Felix Maldonado, Frances Namuswe, PhD, Francis A Guidry, George J Flynn, Gerald B Seaborn, Jr, German Rivera, Gwyn G Dickinson, Hai L Phung, Hai Lien T Phung, Hamet M Toure, PharmD MPH, Hamet Toure, PharmD MPH, Hector J Colon Torres, Herbert M Corbello, Holly Brevig, Howard A Anderson, Howard Anderson, PhD, Ian J Thomson, Ibad U Khan, Israel Santiago, OCM, Ivis L Negron, Ivis L Negrón, Ivis Lnegron Torres, J David Doleski, Jacek Cieslak, PhD, Jacqueline Mdiaz Albertini, James A Lane, James C Maclaughlin, James D Bridges, James I Giefer, James L Dunnie, Jr, Jason F Chancey, Javier O Vega, Jawaid Hamid, Jazmine N Brown, Jeffery A Hangartner, Jennifer D Hollstrom, Jennifer L Schmidt, Joanne E King, Jocelyn C Turner, Joey V Quitania, Jogy George, Johann M Fitch, John A Gonzalez, Jon Park, Jonathan T Little, Jonathan W Chapman, Jorge L Gonzalez, Jorge L Guadalupe, Jose Acruz Gonzalez, Jose Alopez Rubet, Jose E Melendez, DDC, Jose Fpedrode Jesus, Jose M Cayuela, Jose Martinez, Jr, Jose Melendez, Jose R Hernandez, Jose Velez, Joseph F Owens, Joshua P Wireman, Juan Rjimenez Garcia, Juanita P Versace, Juhong Liu, PhD, Junho Pak, Justin A Boyd, Kalavati Suvarna, PhD, Kara D Dobbin, Karen L Kosar, Karl D Hezel, Katherine D Adams, Katherine Szestypalow, Kathy E Craven, Kathy E Noe, Kejun Cheng, Kellia N Hicks, Kenneth H Williams, Kevin A Gonzalez, Kevin D Kallander, Kevin P Foley, Kham Phommachanh, Kim Lthomas Cruse, Kristy A Zielny, Kumar G Janoria, Laiza V Garcia, Langer, Larry K Austin, Larry K Hampton, Lata C Mathew, PhD, Latorie S Jones, Laura Fontan, MS, Laura L Staples, Laurie Nelson, Laurimer Kuilan Torres, Lawrence J Stringer, LCDR Chad N Thompson, LCDR Debra Emerson, Leon L Law, Leslie Arivera Rosado, PhD, Libia M Lugo, Liming Zhang, Linda F Murphy, Linda N Thai, Linda Thai, Lindsey M Schwierjohann, Lisa A Bowden, Lixin Xu, MD, PhD, Lorie S Hannappel, LT Daveta L Bailey, LT Tamara J Henderson, Lucas B Leake, Luis A Carrion, Madushini Dharmasena, PhD, Marcellinus D Dordunoo, Margaret M Annes, Maria C Shih, Maria Cecilia Tami, PhD, Maria Gutierrez Lugo, PhD, Maria Joselopez Barragan, PhD, Maria Pkelly Doggett, MBA, Marie Bbuen Bigornia, Marie F Morin, Marijo B Kambere, PhD, Mark R Mcclain, Marlene G Swider, Marvin D Jones, Mary E Farbman, PhD, Mary E Storch, Maryam Tabatabaie, Matthew B Casale, Matthew F Duff, Maxwell Van Tassell, PhD, Meisha R Sampson, Meisha Waters, Melanie M Walker, Melissa D Ray, Melissa J Garcia, Meredith P Soehl, Investigator, Michael A Charles, Michael A Taylor, Michael D Smedley, Michael E Maselli, Michael R Goga, Michael R Klapal, Michael Shanks, MS, Miguel A Martinez, Mihaly S Ligmond, Monica Cburgos Garcia, Mra Davism, Mra Mcculloughj, Muralidhara B Gavini, PhD, Myriam M Sosa, Nadeem I Chaudhry, Navista C Bolton, Neal L Adams, Nicholas A Violand, Nicole A Lloyd, Nicole E Knowlton, Nina Brahme, PhD, MPH, Noreen Muniz, Omotunde O Osunsanmi, Pankaj H Amin, Parul M Patel, Patricia H Dlugosz, Patrick C Klotzbuecher, Patrick L Wisor, Patsy J Domingo, Patty P Kaewussdangkul, Paul A Bonneau, Paul L Bellamy, Paul L Figarole, Jr, Paul Mouris, Paula R Katz, Peng Zhou, Penny H Mccarver, Peter E Baker, Prabhu P Raju, Rachael L Cook, Rafael Nevarez Nieves, Rajiv R Srivastava, Ram Sihag, PhD, Ramon A Hernandez, Raquel Gonzalez, Raquel Gonzalez Rivera, Rebecca E Dombrowski, Rebecca Rodriguez, Reyes Candau Chacon, PhD, Richard E Needham, Richard Ledwidge (nmi), PhD, Rita K Kabaso, Robert C Coleman, Robert C Steyert, Robert D Tollefsen, Robert J Martin, Robert L Lewis, Jr, Robert Rodriguez, Rochelle L Cross, Roger F Zabinski, Rong Guo, Rose Ashley, Rose M Ashley, Ross J Grigsby, Russell J Glapion, Russell K Riley, Saleem A Akhtar, Samina S Khan, Sandra A Hughes, Sang Bong Lee, Sangeeta M Khurana, PhD, Santiago Gallardo Johnson, Sarah Ibrahim, Sarah Johnson, PhD, Scott B Laufenberg, Scott R Nichols, PhD, Scott T Ballard, Scott W Fox, Sena G Dissmeyer, Seneca D Toms, Shanna N Purdy, Shannon A Gregory, Sharon K Thoma, PharmD, Shawn E Larson, Shirley J Berryman, Simone E Pitts, Sonia R Peterson, State Agency, Stephanie A Slater, MS, Stephen D Brown, Stephen D Eich, Stephen J Koniers, Steve Y Rhieu, PhD, Steven A Gonzales, Steven C Madzo, Steven D Kehoe, Steven Fong, MS, PhD, Steven M Weinman, Steven P Donald, Susan M Jackson, Susan O Oladeji, Susan P Bruederle, Susanna E Ford, Analyst, Susant Hadman, Taichun Qin, PhD, Tamil Arasu, PhD, Temar Q Williams, Teresa I Navas, Terri L Dodds, Thomas C Mclean, CFS, Thomas E Friel, Thomas J Arista, Thuy T Nguyen, LCDR, Tiara Nbrown Crosen, Timothy T Kapsala, Tomika L Bivens, Tonia F Bernard, Toyin B Oladimeji, Tracy K Li, Tricia S Martinez, Truong Xuan Nguyen (Andy), Uttaniti Limchumroon (Tom), Vaishali J Patel, Valshall Patel, Veronica Fuentes, MS, Vidya B Pai, Vien Q Le, Vilmary Negron Rodriguez, Vincent Thomas, Virgilio F Pacio, CSO, Viviana Matta, Walden H Lee, Wayne E Seifert, Wendy G Tan, PhD, William Hallett, PhD, William J Leonard, Xianghong Jing (Emily), PhD, Xiaokuang Lai, PhD, Yanming An, PhD, Yaodong Huang, Yasamin Ameri, Yeissa Chabrier Rosello, Yetao Jin, PhD, Ying Xin Fan, PhD, Youmin Wang, Yumi J Hiramine, Zachary A Bogorad, Zachary L Miller, Zhao Wang, PhD, Zhaoyang Meng, Zhigang Sun, PhD, Zhihao Qiu (Peter), PhD, Zhong Li, PhD, Zhongren Wu, Zonglin Hu

Santos E Camara's Documents

Publish Date Document Type Title
July, 2018 EIR YUNG SHIN PHARM. IND. CO., LTD. - EIR, 2018-07-27
May, 2022 FDA 483 Novo Nordisk Pharmaceutical Industries, LP - Form 483, 2022-05-13
December, 2014 FDA 483 Kaneka Eurogentec SA - Form 483, 2014-12-19
July, 2015 FDA 483 JD & SN Inc. - Form 483, 2015-07-21
April, 2019 FDA 483 Laboratorio Reig Jofre Sa. - Form 483, 2019-04-05
December, 2012 FDA 483 CENEXI - Form 483, 2012-12-11
April, 2023 FDA 483 MERCK SERONO SA - Form 483, 2023-04-06
February, 2017 EIR Bachem Americas, Inc. - EIR, 2017-02-10
September, 2021 FDA 483 Newton Laboratories, Inc. - Form 483, 2021-09-17
March, 2021 FDA 483 Olein Recovery Corp - Form 483, 2021-03-18
September, 2017 FDA 483 AstraZeneca Nijmegen B.V. - Form 483, 2017-09-22
August, 2015 FDA 483 American Specialty Pharmacy - Form 483, 2015-08-05
August, 2022 FDA 483 BIOCON SDN.BHD. - Form 483, 2022-08-30
September, 2013 FDA 483 USV Private Limited - Form 483, 2013-09-06
December, 2014 EIR Vetter Pharma Fertigung GmbH & Co. KG (Ravensburg Helmut-Vetter-Strasse) - EIR, 2014-12-12
September, 2015 FDA 483 Pfizer Healthcare India Private Limited - Form 483, 2015-09-08
January, 2023 FDA 483 ELYSIUM PHARMACEUTICALS LIMITED - Form 483, 2023-01-16
February, 2017 FDA 483 Response Bachem Americas, Inc. - Form 483R, 2018-09-10
September, 2018 FDA 483 Agropharma Laboratories Inc. - Form 483, 2018-09-14
October, 2015 FDA 483 Takeda Pharmaceutical Company Limited - Form 483, 2015-10-30
February, 2020 FDA 483 Terumo BCT Ltd - Form 483, 2020-02-07
September, 2013 FDA 483 Vivimed Life Sciences Private Limited - Form 483, 2013-09-13
June, 2022 FDA 483 LEO Laboratories Ltd. - Form 483, 2022-06-24
December, 2018 FDA 483 DPT Laboratories, Ltd. - Form 483, 2018-12-19
September, 2014 FDA 483 Sandoz GmbH - Form 483, 2014-09-16
December, 2016 FDA 483 Sun Pharmaceutical Industries Limited - Form 483, 2016-12-01
November, 2019 FDA 483 Zhejiang Cheng Yi Pharmaceutical Co., Ltd - Form 483, 2019-12-11
January, 2019 FDA 483 Mankind Pharma Limited - Form 483, 2019-01-13
March, 2017 FDA 483 Boehringer Ingelheim RCV GmbH & Co KG - Form 483, 2017-03-17
June, 2022 FDA 483 TAIRGI TREAD-LIA BAILE NA SCEILGE TEORANTA (DbA Ballinskelligs Veterinary Products [BVP]) - Form 483, 2022-06-17
January, 2019 EIR Piramal Pharma Limited - EIR, 2019-01-18
December, 2018 EIR DPT Laboratories, Ltd. - EIR, 2018-12-14
September, 2015 FDA 483 GLAND PHARMA LIMITED - Form 483, 2015-09-18
January, 2023 FDA 483 APOTHECON PHARMACEUTICALS PRIVATE LIMITED - Form 483, 2023-01-27
July, 2019 FDA 483 Baccinex SA - Form 483, 2019-07-26
March, 2023 FDA 483 Lonza AG - Form 483, 2023-03-28
July, 2018 FDA 483 YUNG SHIN PHARM. IND. CO., LTD. - Form 483, 2018-07-27
March, 2022 FDA 483 Janssen Vaccines Corp. - Form 483, 2022-03-10
November, 2022 FDA 483 AvKARE - Form 483, 2022-11-02
February, 2017 FDA 483 Bachem Americas, Inc. - Form 483, 2017-02-10
May, 2018 FDA 483 Umicore Argentina S.A. - Form 483, 2018-05-11
May, 2017 FDA 483 Hainan Shuangcheng Pharmaceuticals Co., Ltd. - Form 483, 2017-05-26
September, 2022 FDA 483 Novugen Pharma Sdn. Bhd. - Form 483, 2022-09-07
August, 2018 FDA 483 Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. - Form 483, 2018-08-03
August, 2017 FDA 483 D & S Enterprises of Vero Beach LLC - Form 483, 2017-08-09
December, 2014 EIR Kaneka Eurogentec SA - EIR, 2014-12-19
May, 2015 FDA 483 CSPC Ouyi Pharmaceutical Co., Ltd. - Form 483, 2015-05-26
October, 2021 FDA 483 Alcami Carolinas Corporation - Form 483, 2021-10-29
May, 2022 EIR Novo Nordisk Pharmaceutical Industries, LP - EIR, 2022-06-02
March, 2023 EIR Lonza AG - EIR, 2023-07-25
November, 2023 FDA 483 Baxter Healthcare Corporation - Form 483, 2023-11-29

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more